Back

Serum Let-7b and AKT3 predict cardiovascular death in type 2 diabetes: insights from miRNA profiling and target prediction

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting cardio-renal-metabolic disease (1) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Hacer Erva Evirgen

Ankara (Turkiye)

6 More presentations in this session

Presentation thumbnail
Machine learning-based all-cause mortality risk assessment integrating novel biomarkers in patients with suspected or known coronary artery disease: the AI-ANOX-EXCEED-J Study
Doctor H. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Combined assessment of stress hyperglycemia ratio and hemoglobin glycation index to predict mortality after coronary revascularisation: a machine learning study
Miss L. Runqian (CN)
Abstract
Presentation thumbnail
Relationship between atherosclerotic burden and subclinical cardiac dysfunction in Type 2 Diabetes
Doctor T. Jinadu (Leicester, GB)
Abstract
Presentation thumbnail
Fourteen-year risk of MACE stratified by NT-proBNP and inflammatory biomarkers in type 2 diabetes
Doctor H. Bahrami (Herlev, DK)
Abstract
Presentation thumbnail
Integrating genetic, clinical, and behavioural factors may improve the prediction of type 2 diabetes
Doctor F. Escorcio Silva (Funchal, PT)
Abstract

Access the full session

Session thumbnail
Predicting cardio-renal-metabolic disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Identifying potential mirnas and hub genes for coronary artery disease prognosis using integrative approaches
13 May 2024
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
27 August 2022
thumbnail
Congress Presentation
MicroRNAs in circulating microvesicles and plasma as biomarkers that complement the clinical diagnosis of diabetic dyslipidemia and its complications
30 April 2022
thumbnail
Congress Presentation
Cardiac biomarkers and cardiovascular side effects are associated with a reduced mortality of oncological patients receiving BRAF/MEK-Inhibitor therapy
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources